Medela Reports Their Portable Medical Surgical and Airway Suction Devices Offers a Safer Alternative to Piped Vaccum Systems

Medela reports their healthcare mobile suction devices are a safer alternative to wall vacuum and can help expand critical care capacity and support UK hospitals in the fight against COVID-19.

Medela notes they have been used in Europe and worldwide. The company’s portable medical suction machines are designed to provide crucial suction and fluid removal during respiratory treatment provided with ventilators.

Traditionally, hospitals ensure a patient’s airway is clear by utilizing suction that relies on central wall piped vacuum. However, guidance published by the National Health Service (NHS) advises hospitals against using piped vacuum to support infectious disease units (IDU) to reduce the risk of virus spread and cross-contamination.

A previous study looking at contamination rates for wall-mounted suction units discovered contamination on over 30% of devices. Hence, portable medical suction machines are recommended for COVID-19 care. Medela offers a range of portable suction pumps which are available with a virus filter capable of reducing cross-contamination from COVID-19 with filtration efficiency of greater than 99.99987%.

These compact devices offer flexibility to hospitals while reducing the risk of viral transmission. When used with disposable collection systems, portable suction machines reduce staff exposure to hazardous fluids, while devices equipped with virus filters further reduce the risk of cross-contamination and viral exposure to staff.

Rob Rennel, Business Unit Manager at Medela comments: “Medela’s range of portable medical surgical and airway suction devices facilitate the removal of lung secretions in the inflammatory process of coronavirus – offering life-saving support to critical care patients while mitigating risks facing staff on the frontlines.”

Dr. Stephen Cole, Consultant in Intensive Care Medicine at Ninewells Hospital in Dundee, Scotland, adds: “The new reality is that we will need to rapidly increase intensive care units (ICU) bed capacity within 2- or 3-weeks’ notice. We need to prepare, need to plan, need to stock the hardware that we need such as ventilators, suction pumps, and monitors.”

While most patients with COVID-19 recover over time without the need for special treatment, in more critical cases the infection can trigger pneumonia, causing the lungs to become more inflamed and fill with fluid. Research shows approximately 14% of COVID-19 patients require hospitalization and oxygen support, while a further 5% require admission to an Intensive Care Unit (ICU) and supportive therapies such as intubation and ventilation.

Standard of care in the ICU requires each patient to be provided with a single suction device, which helps to decrease the risk of lung infections, prolonged hypoxia, and pooling of secretions in the lung.

SourceMedela

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.